Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease. - Wikidata - awgldk - TriplyDB

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

http://www.wikidata.org/entity/Q33404815

about

Recommendations for transfusion therapy in neonatology A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy.Exchange Transfusion for Severe Neonatal Hyperbilirubinemia: 17 Years' Experience from Vojvodina, Serbia Management of haemolytic disease of the foetus & newborn: steps to improve the outcomes Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation.Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study.Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization.Improving the management and outcome in haemolytic disease of the foetus and newborn.

P2860

Q26786617-3D073157-35B0-48A7-85C0-F4F5B87C2F8F Q30829609-3BE9A822-C96C-493C-94AC-8953A83CA2E5 Q34411195-B5DF7A6D-1E59-4AD2-85BA-FB61E8AF57B6 Q36679569-FB09DEBE-66DA-4EFF-B749-4B94D314A044 Q37156646-BAA085D4-C36D-40A5-9C0C-2273BB0F40CC Q37306762-5C0999E8-ABDE-4710-B77D-3BB35862373E Q40348688-9FC0D151-19E7-4EA9-97D8-DE1C62F184A0 Q40401530-C04D511B-1EDC-44C4-9E6E-A8BF3A917748 Q42907989-B8F44597-9C81-4EEF-BF59-1C7BA5AD6D98

P2860

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

http://www.wikidata.org/entity/Q33404815

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

@ast

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

@en

type

label

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

@ast

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

@en

prefLabel

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

@ast

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

@en

P1433

Q33404815-776191CD-7170-44DD-90C4-204137FBFD76

P1476

Q33404815-F745F738-F6B3-4E56-913B-901963E36C10

P2093

Q33404815-063C871F-8BFB-4F9B-8B2F-F24186368315

Q33404815-4B86DAFE-570E-44F2-8D1C-436D2FF0F31B

Q33404815-9DC24157-1F2C-4AF5-BC5F-AAAA028CC616

Q33404815-9F27DCA5-D583-41F5-BB28-E258CED5397F

Q33404815-C05C43A7-04D0-4433-B16F-68D4AE1B4451

Q33404815-E2162500-8BAA-41C7-8F33-BB66EE981C93

P2860

Q33404815-096F7481-61C3-4284-892D-B7069EA0D090

Q33404815-11A7B291-68BB-4984-A4B4-370E0056D589

Q33404815-13D00463-19AC-4867-BFE5-8CC0679FE341

Q33404815-20933067-5AAD-4952-9E6A-8F2D2899BFFE

Q33404815-29BCF67E-98B3-416B-9EBB-FEB8BE22562A

Q33404815-2A4B95FC-C973-4720-BA93-DF9785656DE8

Q33404815-3B78F4B8-3B15-4B17-819D-670A2022D033

Q33404815-3D7753F6-8E64-4AF6-892A-6E4A5E49FDC3

Q33404815-46D63228-3766-409E-B905-78AF796A2E54

Q33404815-592FDD80-F666-4023-AB94-23D35EA74789

P304

Q33404815-3AE3D6B5-84AC-4F50-96B9-A663B811A0E9

P31

Q33404815-F00CF953-574A-48F8-ADC3-5B4155277731

P356

Q33404815-732CD759-AF11-43EA-AE86-6F425F385167

P407

Q33404815-F032BDA0-40DA-4208-8E8C-E5AB4F2D073C

P433

Q33404815-B872FC57-384B-4370-BCD2-916E1B8B6C17

P478

Q33404815-B6225F4F-2510-404D-BF11-967F6988ABA1

P50

Q33404815-DA8F8EC4-2903-45F6-84B4-8723F64BCE98

P577

Q33404815-F9EF0451-3EA3-4FBE-8489-EEEB58778BBE

P5875

Q33404815-699FE69C-160C-4BB2-90F2-9E9D743FFC46

P698

Q33404815-41FAE545-836E-4A60-ABF6-3B1B2060028B

P356

P1433

P1476

Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.

@en

P2093

Anneke Brand

http://www.w3.org/2001/XMLSchema#string

Dick Oepkes

http://www.w3.org/2001/XMLSchema#string

Enrico Lopriore

http://www.w3.org/2001/XMLSchema#string

Erik W van Zwet

http://www.w3.org/2001/XMLSchema#string

Mirjam E A Rath

http://www.w3.org/2001/XMLSchema#string

Vivianne E H J Smits-Wintjens

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse events associated with neonatal exchange transfusion in the 1990s.

A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality.

Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome.

Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization.

Thrombocytopenia at birth in neonates with red cell alloimmune haemolytic disease.

Adverse events associated with exchange transfusion in healthy and ill newborns.

Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging.

Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

Treatment of jaundice in low birthweight infants.

P304

141-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000343261

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233908560

http://www.w3.org/2001/XMLSchema#string

P698

23235106

http://www.w3.org/2001/XMLSchema#string